Facet browsing currently unavailable
Page 1 of 1 results
Sort by: relevance publication year
Showing DOI matching
10.1056/NEJMoa1613683
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma JOURNAL ARTICLE published 16 March 2017 in New England Journal of Medicine |